Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Analyst Earnings Estimates

NASDAQ:JBSS - Nasdaq - US8004221078 - Common Stock - Currency: USD

73.18  +0.8 (+1.11%)

After market: 73.18 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
JBSS revenue by date.JBSS revenue by date.
955.9M
11.35%
1B
4.58%
1.067B
6.71%
EBITDA
YoY % growth
JBSS ebitda by date.JBSS ebitda by date.
103.4M
-0.10%
110.7M
7.06%
107.542M
-2.85%
EBIT
YoY % growth
JBSS ebit by date.JBSS ebit by date.
85.1M
-0.12%
90.2M
5.99%
82.961M
-8.03%
Operating Margin
JBSS operating margin by date.JBSS operating margin by date.
8.90%9.02%7.78%
EPS
YoY % growth
JBSS eps by date.JBSS eps by date.
5.17N/A5.16

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.16
-29.27%
%
Q1 2025
Q2Q % growth
1.00
-33.77%
%
Q4 2024
Q2Q % growth
0.86
-31.75%
%
Q3 2024
Q2Q % growth
1.15
-14.81%
%
Q2 2024
Q2Q % growth
1.64
13.10%
%
Q1 2024
Q2Q % growth
1.51
12.69%
%
Q4 2023
Q2Q % growth
1.26
-16.00%
%
Q3 2023
Q2Q % growth
1.35
32.35%
%
Q2 2023
Q2Q % growth
1.45
27.19%
%
Q1 2023
Q2Q % growth
1.34
-11.26%
%
Q4 2022
Q2Q % growth
1.50
40.19%
%
Q3 2022
Q2Q % growth
1.02
-19.69%
1.010.011.01%
Q2 2022
Q2Q % growth
1.14
-33.72%
1.44-0.30-20.73%
Q1 2022
Q2Q % growth
1.51
36.04%
1.420.096.50%
Q4 2021
Q2Q % growth
1.07
20.22%
1.17-0.10-8.78%
Q3 2021
Q2Q % growth
1.27
8.55%
1.200.075.52%
Q2 2021
Q2Q % growth
1.72
13.16%
1.460.2617.92%
Q1 2021
Q2Q % growth
1.11
-0.89%
1.030.087.75%
Q4 2020
Q2Q % growth
0.89
-9.18%
0.93-0.04-4.12%
Q3 2020
Q2Q % growth
1.17
30.00%
0.670.5073.80%
Q2 2020
Q2Q % growth
1.52
55.10%
1.140.3833.05%
Q1 2020
Q2Q % growth
1.12
96.49%
0.930.1920.66%
Q4 2019
Q2Q % growth
0.98 0.670.3145.57%
Q3 2019
Q2Q % growth
0.90 0.670.2333.69%
Q2 2019
Q2Q % growth
0.98 1.02-0.04-3.92%
Q1 2019
Q2Q % growth
0.57 0.96-0.39-40.55%
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
301.07M
3.38%
%
Q1 2025
Q2Q % growth
276.2M
17.98%
%
Q4 2024
Q2Q % growth
269.57M
15.09%
%
Q3 2024
Q2Q % growth
271.88M
13.98%
%
Q2 2024
Q2Q % growth
291.22M
6.17%
%
Q1 2024
Q2Q % growth
234.11M
-7.32%
%
Q4 2023
Q2Q % growth
234.22M
-9.11%
%
Q3 2023
Q2Q % growth
238.54M
9.12%
%
Q2 2023
Q2Q % growth
274.3M
8.33%
%
Q1 2023
Q2Q % growth
252.6M
11.62%
%
Q4 2022
Q2Q % growth
257.7M
24.67%
%
Q3 2022
Q2Q % growth
218.6M
5.15%
219.81M-1.21M-0.55%
Q2 2022
Q2Q % growth
253.2M
8.39%
244.39M8.81M3.60%
Q1 2022
Q2Q % growth
226.3M
7.61%
222.36M3.94M1.77%
Q4 2021
Q2Q % growth
206.7M
1.22%
202.16M4.54M2.25%
Q3 2021
Q2Q % growth
207.9M
-1.75%
206.75M1.15M0.56%
Q2 2021
Q2Q % growth
233.6M
-5.19%
240.82M-7.22M-3.00%
Q1 2021
Q2Q % growth
210.3M
-3.44%
211.75M-1.45M-0.68%
Q4 2020
Q2Q % growth
204.2M
-5.81%
225.11M-20.91M-9.29%
Q3 2020
Q2Q % growth
211.6M
4.86%
213.38M-1.78M-0.83%
Q2 2020
Q2Q % growth
246.4M
-2.72%
268.67M-22.27M-8.29%
Q1 2020
Q2Q % growth
217.8M
6.61%
215.73M2.07M0.96%
Q4 2019
Q2Q % growth
216.8M 216.24M560K0.26%
Q3 2019
Q2Q % growth
201.8M 201.04M760K0.38%
Q2 2019
Q2Q % growth
253.3M 280.19M-26.89M-9.60%
Q1 2019
Q2Q % growth
204.3M 230.83M-26.53M-11.49%
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A